Protalix BioTherapeutics
PLX
#8910
Rank
ยฃ0.10 B
Marketcap
ยฃ1.31
Share price
1.74%
Change (1 day)
2.26%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): -ยฃ0.03251

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.03000. In 2024 the company made an earnings per share (EPS) of ยฃ0.03000 a decrease over its 2023 EPS that were of ยฃ0.08999.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.03251-208.39%
2024ยฃ0.03000-66.67%
2023ยฃ0.08999-138.71%
2022-ยฃ0.23-50%
2021-ยฃ0.46181.82%
2020-ยฃ0.16-82.11%
2019-ยฃ0.92-31.67%
2018-ยฃ1.35-72.31%
2017-ยฃ4.87124.14%
2016-ยฃ2.17-147.54%
2015ยฃ4.57-290.63%
2014-ยฃ2.406.67%
2013-ยฃ2.25130.77%
2012-ยฃ0.97-69.77%
2011-ยฃ3.2219.44%
2010-ยฃ2.70-12.2%
2009-ยฃ3.0736.67%
2008-ยฃ2.25-37.5%
2007-ยฃ3.6050%
2006-ยฃ2.403.23%
2005-ยฃ2.32138.46%
2004-ยฃ0.97-74%
2003-ยฃ3.75-0%
2002-ยฃ3.75-50%
2001-ยฃ7.50233.33%
2000-ยฃ2.25-84.21%
1999-ยฃ14.25-24%
1998-ยฃ18.75-600%
1997ยฃ3.75-16.67%
1996ยฃ4.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-ยฃ0.08249 175.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ3.23-10,875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.29-4,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-1,675.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel